New: Clinical trial search, funded by the National Cancer InstituteNew: NCI-funded clinical trial search

How do you sequence luspatercept and imetelstat for treatment of anemia in MDS?

Ask a clinical question

Answers grounded in the literature and physician expertise.

Related Questions

How do you modify HMA treatments for a patient with high-risk MDS experiencing prolonged cytopenias after each cycle?

How do you approach imetelstat therapy in MDS patients with baseline neutropenia or thrombocytopenia?

Which neoadjuvant/adjuvant chemotherapy regimen would you select in a patient with resectable stage IB pancreatic head adenocarcinoma and MDS-SF3B1 on luspatercept (baseline Hgb of 8-9 g/dL)?

About Mednet

A community where doctors find answers to medicine's toughest questions.

Verified, credentialed physicians
45,000+ members across 23 specialties
Free CME and MOC credit

Evidence Meets Expertise

Community

Browse Specialties
Code of Conduct
AI Community Guidelines

Tools

Mednet AI
TrialMatch
Mobile App

Company

About
Careers
Events
Our Work
Blog

Support

FAQs
Contact Us
Programs

Legal

Privacy Policy
Terms of Service

© 2026 Mednet Inc. All rights reserved.